536565 Stock Overview
Engages in the trading of pharmaceuticals and related products in India.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Trimurthi Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹18.94 |
| 52 Week High | ₹18.94 |
| 52 Week Low | ₹8.00 |
| Beta | 0.45 |
| 11 Month Change | 4.99% |
| 3 Month Change | 10.18% |
| 1 Year Change | 98.95% |
| 33 Year Change | 118.20% |
| 5 Year Change | 337.41% |
| Change since IPO | 73.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| 536565 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 0% | 1.5% | 1.0% |
| 1Y | 98.9% | 39.3% | 43.7% |
Return vs Industry: 536565 exceeded the Indian Healthcare industry which returned 39.3% over the past year.
Return vs Market: 536565 exceeded the Indian Market which returned 43.7% over the past year.
Price Volatility
| 536565 volatility | |
|---|---|
| 536565 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 536565 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 536565's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 7 | Aditya Bhangadia | www.trimurthidrugs.com |
Trimurthi Limited, together with its subsidiaries, engages in the trading of pharmaceuticals and related products in India. The company is involved in the retail pharmacy business; and distribution of pharmaceutical products. It also trades in shares and securities; and offers marketing services.
Trimurthi Limited Fundamentals Summary
| 536565 fundamental statistics | |
|---|---|
| Market cap | ₹189.40m |
| Earnings (TTM) | ₹104.00k |
| Revenue (TTM) | ₹45.31m |
1,821x
P/E Ratio4.2x
P/S RatioIs 536565 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 536565 income statement (TTM) | |
|---|---|
| Revenue | ₹45.31m |
| Cost of Revenue | ₹38.36m |
| Gross Profit | ₹6.95m |
| Other Expenses | ₹6.85m |
| Earnings | ₹104.00k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.01 |
| Gross Margin | 15.34% |
| Net Profit Margin | 0.23% |
| Debt/Equity Ratio | 0% |
How did 536565 perform over the long term?
See historical performance and comparison